Gregory P. Madison

2015

In 2015, Gregory P. Madison earned a total compensation of $6.3M as Chief Executive Officer and President at Keryx Biopharmaceuticals, a 109% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$141,750
Option Awards$5,135,484
Salary$517,788
Stock Awards$485,768
Other$9,000
Total$6,289,790

Madison received $5.1M in option awards, accounting for 82% of the total pay in 2015.

Madison also received $141.8K in non-equity incentive plan, $517.8K in salary, $485.8K in stock awards and $9K in other compensation.

Rankings

In 2015, Gregory P. Madison's compensation ranked 1,157th out of 13,638 executives tracked by ExecPay. In other words, Madison earned more than 91.5% of executives.

ClassificationRankingPercentile
All
1,157
out of 13,638
92nd
Division
Manufacturing
410
out of 5,187
92nd
Major group
Chemicals And Allied Products
148
out of 1,857
92nd
Industry group
Drugs
114
out of 1,531
93rd
Industry
Pharmaceutical Preparations
93
out of 1,179
92nd
Source: SEC filing on April 26, 2017.

Madison's colleagues

We found five more compensation records of executives who worked with Gregory P. Madison at Keryx Biopharmaceuticals in 2015.

2015

Ron Bentsur

Keryx Biopharmaceuticals

Chief Executive Officer

2015

John Neylan

Keryx Biopharmaceuticals

Chief Medical Officer

2015

James Oliviero

Keryx Biopharmaceuticals

Chief Financial Officer

2015

Brian Adams

Keryx Biopharmaceuticals

General Counsel

2015

Scott Holmes

Keryx Biopharmaceuticals

Chief Financial Officer

In-depth

You may also like